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effectiveness and cost effectiveness of many non-
surgical treatments—such as self care, analgesia,
anti-inflammatory drugs, and physiotherapy directed
exercise—is lacking. We cannot assume that generic
programmes are the best way to achieve changes in
confidence, attitudes, and other psychosocial variables
in all patients with osteoarthritis, or that such changes
will be large enough to alter the future course of the
disease. The government is committed to increasing
the number of places on the expert patient
programme, which is similar to the challenging arthri-
tis programme, from the current capacity of 12 000 to
100 000 by 2012. The growing body of evidence about
self management programmes stresses the need to
question whether this policy will achieve its desired
outcomes, namely long term gains in health coupled
with reduced use of healthcare services.
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Advance care planning in primary care
Uncomfortable, but likely to engender hope rather than dispel it
Of the various trajectories of physical decline,organ failure is often the most difficult toplan for in advance because of its unpredict-
ability.1 The qualitative study by Davison and Simpson
in this week’s BMJ challenges the notion that early dis-
cussion of planning for the end of life will destroy hope
rather than create it. Rather, it allowed patients dying of
end stage renal failure and their carers to reflect on
and reorient their aspirations.2 A wealth of evidence
indicates that many elderly patients want to discuss
these issues with their healthcare professionals, but this
rarely happens even when (as in the United Kingdom)
continuity of care with a trusted general practitioner is
available.3 4 The main barrier is probably doctors’
reluctance to raise the issue of planning for death
because of the largely unfounded fear of destroying
hope.
Advance care planning is practised in Australia,
Canada, and the United States.5–7 It is also proposed as
a cornerstone of the emerging National Health Service
national end of life care strategy in England
(http://eolc.cbcl.co.uk/eolc). It should enable provi-
sion of services in accordance with patients’ wishes—for
example, patients choosing home care rather than
other places.8
Advance care planning is now defined as a process
of discussion between a patient and professional carer,
which sometimes includes family and friends. This
dialogue has two outcomes—an “advance statement,”
which describes the patient’s positive preferences and
aims for future care; and an “advance decision,” which
provides informed consent for refusal of specific treat-
ment if the patient is not competent to make such a
decision in the future. The last of these outcomes is
especially relevant as the new Mental Capacity Act in
England is due to be enacted in April 2007.9 The
focus of advance care planning is thus shifting from
eliciting refusal of treatment from a minority of
patients to identifying the preferences for care of most
patients.
Internationally, advance care planning can be
incorporated into primary care. In the UK this year, the
new general practice contract has established practice
based patient registers, including one for people who
might benefit from supportive or palliative care and
who might die within the next 12 months. Guidance
has been developed through the Gold Standards
Advance care planning: five point plan for
primary care
(1) Identify patients who may be in their last 12
months of life and add them to the practice’s palliative
care register
(2) Assess their current health and social needs
(3) Sensitively raise the following points with patients
and their family or carers
What elements of care are important to you and what
would you like to happen? What would you not wish
to happen? Do you have a person who is willing to be
a proxy or have lasting power of attorney?
If your condition deteriorates, where would you like
to be cared for (first and second choices)?
Have you any other special preferences, requests, or
comments?
Do you have a view on resuscitation if your heart
suddenly stops?
These preferences should then be communicated to
other services
(4) Provide proactive personalised care and review this
regularly with the patient and family or carers
(5) If patients do not want a specific treatment should
incapacity arise, seek specialist help to initiate a legal
“advance decision”
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Framework programme (which is now used by over a
third of UK practices) to identify and care for such
patients.10 11 The box shows a possible scheme to use
advance care planning to improve end of life care.
Realistic information, sensitively provided, helps
patients and their families to maintain a feeling of nor-
mality and allows them to develop new coping
strategies. Such discussions engender hope. Such hope
is not for a cure but for understanding the process of
dying and for reassurance that support will be given
during a variety of eventualities. Calman described
quality of life in terms of the gap between patients’
expectations and reality.12 Our role may be to negotiate
realistic changes in expectation (by discussing likely
trajectories, prognosis, and advance care planning) and
concurrent improvements in reality (with good
symptom control and support services) to improve
quality of life in the final months and weeks.
Davison and Simpson’s study is a small but impor-
tant step in enhancing our understanding of the
importance of notions of hope, even when to the out-
sider it seems that all hope is lost. Their findings need
to be confirmed in other populations (the patients
studied were almost exclusively white) and through
implementation studies to evaluate how best the
proactive approach improves outcomes of patients.
That said, considerable evidence supports the integra-
tion of advance care planning into routine practice as
part of good care for all people with progressive life
threatening illnesses. Planning for death with our
patients may be an uncomfortable concept but is likely
to engender hope rather than dispel it.
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Age related macular degeneration
Better tools are needed to measure quality of life and visual outcomes
Wet (also known as neovascular or exudative)age related macular degeneration is acommon condition of poorly understood
aetiology that affects around two million elderly
people in Europe.1 In the United Kingdom, in about a
quarter of a million people wet macular degeneration
causes bilateral visual impairment of sufficient severity
that they are registered as partially sighted or blind.2 If
only one eye is affected the onset of disease may go
unnoticed by the patient. Wet macular degeneration is
usually bilateral though, and when the second eye
becomes affected the impact on the patient is
devastating.3
Good vision is often taken for granted. It is an
important prerequisite for a socially fulfilling and
active lifestyle. Wet macular degeneration affecting
both eyes has serious consequences for quality of life.
The psychosocial and functional impact of sight
loss due to this condition is reviewed in a paper by
Mitchell and Bradley commissioned by the Interna-
tional Age Related Macular Degeneration Alliance.4 A
major problem is defining quality of life; this is
highlighted by the lack of consensus in various
questionnaires that aim to measure it.5 Mitchell and
Bradley question the relevance of current instruments
used to monitor health status, quality of life, and visual
functioning in patients with age related macular
degeneration. This is supported by the fact that popu-
lar instruments for measuring health status—such as
the medical outcomes study short form 36 (SF-36),
health utilities index 3 (HUI3), and EuroQol
(EQ-5D)—do not capture the effects of sight loss on
quality of life.4
Many people with neovascular macular degenera-
tion report excellent health, either because the disease
affects only one eye or they do not perceive sight loss
as a decline in their general health status. Despite this,
they are shocked by how rapidly loss of sight
progresses and frightened at the thought of going
blind and thus losing their independence, features that
are not captured by existing instruments for measuring
health status. Even when these instruments are used in
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